DYNE THERAPEUTICS, INC. (DYN)
TALEN ENERGY CORP (TLN)
Talen Energy Announces Pricing of Senior Notes
PYXIS ONCOLOGY, INC. (PYXS)
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
GOODRX HOLDINGS, INC. (GDRX)
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call
COMFORT SYSTEMS USA INC (FIX)
Comfort Systems USA Announces First Quarter 2026 Conference Call and Webcast
4D MOLECULAR THERAPEUTICS, INC. (FDMT)
4DMT Announces New Employment Inducement Grants
PARAMOUNT SKYDANCE CORP (PSKY)
Paramount Declares Quarterly Cash Dividend
ALX ONCOLOGY HOLDINGS INC (ALXO)
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
SEALSQ CORP (LAES)
SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders
SAVARA INC (SVRA)
Savara Announces New Employment Inducement Grant
THERIVA BIOLOGICS, INC. (TOVX)
Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting
CAMP4 THERAPEUTICS CORP (CAMP)
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
COREWEAVE, INC. (CRWV)
CoreWeave Announces Date of First Quarter 2026 Financial Results and Conference Call
VERA BRADLEY, INC. (VRA)
Vera Bradley Terminates Existing Shareholder Rights Plan